Sunesis Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference
Mar 28, 2017 11:01 am UTC| Business
SOUTH SAN FRANCISCO, Calif., March 28, 2017 -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Eric Bjerkholt, Executive Vice President Corporate Development and Finance and Chief Financial Officer of...
Cempra Withdraws Solithromycin Marketing Authorization Application in Europe
Mar 28, 2017 11:01 am UTC| Business
CHAPEL HILL, N.C., March 28, 2017 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and community settings to meet critical...
miRagen Therapeutics to Present at the Needham and Company 16th Annual Healthcare Conference
Mar 28, 2017 11:01 am UTC| Business
BOULDER, Colo., March 28, 2017 -- Miragen Therapeutics, Inc. (Nasdaq:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today announced that...
Mar 28, 2017 11:01 am UTC| Business
ATLANTA, March 28, 2017 -- Innovative Architects (https://www.innovativearchitects.com/) has been awarded a 2017 Top Workplaces honor by The Atlanta Journal-Constitution. The Top Workplaces lists are based solely on the...
REGENXBIO Enhances and Expands Scientific Leadership
Mar 28, 2017 11:01 am UTC| Business
ROCKVILLE, Md., March 28, 2017 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV®...
VBL Therapeutics to Present at the H.C. Wainwright NASH Investor Conference
Mar 28, 2017 11:00 am UTC| Business
TEL AVIV, Israel, March 28, 2017 -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today...
Board of Directors of StoneMor Partners Announces Retirement of CEO
Mar 28, 2017 10:59 am UTC| Business
TREVOSE, Pa., March 28, 2017 -- The Board of Directors (the “Board”) of StoneMor GP LLC (“StoneMor GP”), the general partner of StoneMor Partners L.P. (NYSE:STON) (“StoneMor” or the “Partnership”), today announced that...